NCT07060794View on ClinicalTrials.gov

Tafenoquine and DHA-piperaquine (TADORE- Plus)

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

280

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions

Vivax Malaria

Interventions

DRUG

Tafenoquine

Tafenoquine in combination with DHA-piperaquine

All Listed Sponsors

lead

Menzies School of Health Research

OTHER